HPV-specific T-cells can be generated from naïve T cells for use as immunotherapeutic strategy for immunocompromised patients

Human papilloma virus is a known cause of cervical cancer, squamous cell carcinoma, and laryngeal cancer. Although treatments exist for HPV-associated malignancies, patients unresponsive to these therapies have a poor prognosis. Recent findings from vaccine studies suggest that T cell immunity is es...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cytotherapy
Autori principali: McCormack, Sarah E., Cruz, Conrad Russell Y., Wright, Kaylor E., Powell, Allison B., Lang, Haili, Trimble, Cornelia, Keller, Michael D., Fuchs, Ephraim, Bollard, Catherine M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6731765/
https://ncbi.nlm.nih.gov/pubmed/29331266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2017.11.010
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi